Jefferies Q2 Portfolio Shifts: Heavy Investments in Tech & Healthcare Stocks

As of June 30, 2026, Jefferies Financial Group Inc.'s portfolio has undergone notable shifts during the second quarter. The total value stands at $10.04 billion, reflecting changes from previous periods.

The investor demonstrated a strong focus on Technology stocks this quarter. Among the top holdings by weight, SPY, the SPDR S&P 500 ETF Trust, saw its position increase significantly with shares rising by approximately 83% compared to the prior period (SPY). Similarly, AAPL, Apple Inc., experienced a massive share increase of over 240%, representing substantial buying activity (AAPL). Other Technology names like AMD (Advanced Micro Devices) also showed significant growth, with shares increasing by about 41.5% (AMD). However, within the same sector, there were contrasting moves; NVDA (NVIDIA Corporation) saw a slight decrease in its portfolio allocation percentage (-6.41%) and share count (NVDA). The Technology sector itself accounted for about 13.89% of the total portfolio value.

Parallel to Technology, Jefferies showed considerable interest in Healthcare stocks during Q2. TNGX, Tango Therapeutics Inc., entered the portfolio as a new position (TNGX). Meanwhile, within the top holdings list, RARE (Ultragenyx Pharmaceutical) saw an extraordinary increase of over 5902% in its portfolio allocation (RARE). The Healthcare sector represented approximately 15.63% of the total value, highlighting its importance to Jefferies' investment strategy.

In addition to Technology and Healthcare, there were significant developments in other sectors. CLSK, Cleanspark Inc., which is categorized under Financial Services, saw a massive increase in shares (over 13,706%) adding substantially to its portfolio allocation (CLSK). Another notable entry was BBVA, Banco Bilbao Vizcaya Argenta, which joined the portfolio with a 100% increase in shares (BBVA). The Financial Services sector allocation increased to about 7.19%, while Real Estate saw an addition of NNN, NNN REIT Inc., with a significant share increase (NNN). These examples illustrate Jefferies' active buying stance across different segments.

Conversely, the investor also disposed of certain positions during Q2. The XBI, SPDR Series Trust (which focuses on biotech), saw a decrease in its portfolio allocation percentage by 3.12% (XBI). There were also substantial reductions, such as the QQQ, iShares Core Nasdaq 100 ETF, which experienced a nearly 23.4% decrease in shares (QQQ). Furthermore, several holdings showed significant declines or exits: PRCH (Porch Group) was completely liquidated (-98.88%), while others like VSTS, NOK (Nokia), HYG, and CGON saw substantial reductions in their allocations (VSTS), (NOK), (HYG), and (CGON). These exits suggest a strategic rebalancing or profit-taking approach.

The overall portfolio allocation shows that Jefferies maintains exposure across diverse sectors, with Technology being the largest sector by value at $1.39 billion (13.89%) and Healthcare close behind at $1.57 billion (15.63%). The remaining allocations include Financial Services ($0.72B), Consumer Cyclical ($0.86B), Real Estate ($0.26B), Industrials ($0.06B), Communication Services ($0.36B), Basic Materials ($0.04B), and Utilities ($0.19B). The total portfolio value is $10.04 billion, with the remaining portion classified as 'Unknown'.